The Cancer of the Pancreas Screening-5 (CAPS5) Study
Pancreas | Prevention
What is the purpose of this trial?
The purpose of the study is to evaluate pancreatic fluid mutations and circulating pancreatic epithelial cells as accurate markers of neoplasia by comparing their prevalence in cases with sporadic pancreatic neoplasia to healthy and disease controls; to compare the prevalence of pancreatic fluid mutations and circulating pancreatic epithelial cells among a prospective cohort of individuals with sporadic pancreatic cysts undergoing pancreatic surveillance.
- Ages18 years and older
- Trial withAmerican Association for Cancer Research
- Start Date05/11/2015
- End Date10/30/2021
- Last Updated06/22/2018
- Study HIC#1408014448